About Reaction Biology
Reaction Biology is a Healthcare company based in United States founded in 2001. In vitro enzyme activity assays, secializing in kinase epigenetic HTS and profiling. The company has 77 employees. Reaction Biology has completed 3 acquisitions, including Bioassay, Peptide Specialty Laboratories and ProQinase. Its website reactionbiology.com draws about 16 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its legal entity is Reaction Biology Europe GmbH. Its competitors include Chroma Medicine, FOXO Technologies and PhenoVista; 2 of its 3 listed competitors have raised funding.
Company details
Reaction Biology was founded in 2001 in the United States as a contract research organization focused on biotechnology. In vitro enzyme activity assays are offered for high-throughput screening and profiling, with specialization in kinase, epigenetic regulatory enzymes, and protease activities. Services include compound library screening, cell-based assays, CYP and hERG profiling, custom assay development, and protein microarray applications, supporting drug discovery efforts across various therapeutic areas.
- Headquarters United States
- Employees 77
- SectorsHealthcare
- Email••••••••
- Website reactionbiology.com
- Social LinkedIn X Facebook
- Legal Name Reaction Biology Europe Gmbh
Funding Insights of Reaction Biology
- Total Rounds 16
- First Round $750,869
(Aug 2005)
- Investors Count 5
Latest 10 of 16 funding rounds of Reaction Biology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | Private Equity Round | – | Cobepa | – | |
| Apr 2016 | $247,791 | Grant | – | – | |
| Jul 2014 | $287,650 | Grant | – | – | |
| Jun 2014 | $287,650 | Grant | – | – | |
| Sep 2011 | $1.39M | Grant | – | – | |
| Aug 2011 | $1.39M | Grant | – | – | |
| Jul 2010 | $1.2M | Grant | – | – | |
| May 2009 | $252,860 | Grant | – | – | |
| Apr 2009 | $252,860 | Grant | – | – | |
| Apr 2009 | $1.37M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Reaction Biology
Reaction Biology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, National Cancer Institute and Cobepa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cobepa is recognized as an independent investment company. | cobepa.com | Brussels, Belgium | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Research is conducted to advance translational science for health solutions. | ncats.nih.gov | Rockville, United States | ||
Cancer research is conducted and supported by the institute. | cancer.gov | Bethesda, United States | ||
Research on dental and craniofacial health is conducted. | nidcr.nih.gov | Bethesda, United States |
Investor details for Reaction Biology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Reaction Biology
17 people are tracked at Reaction Biology (15 in leadership, 2 in team); the tracked headcount is 77.
| Name | Role | Group |
|---|---|---|
Ekaterina Kuznetsova | Senior Director of Product Development, USA | Leadership |
Joanne McCorriston | Director Business Development | Leadership |
Cynthia Obodozie | Head of In Vivo Pharmacology Project Management & Animal Affairs | Leadership |
Safnas F. Abdulsalam | Director of Assay Development, USA | Leadership |
Richard S. Kollender | CFO & Chief Business Officer | Leadership |
Sebastian Dempe | CEO, Germany | Leadership |
Neena Marano | Chief of Staff to the CEO | Leadership |
Eric S. Bodle | VP, Global Scientific Operations | Leadership |
Andrew Khouri | VP, Corporate Development | Leadership |
Janine Lumio Wheaton | Chief People Officer | Leadership |
Roland Carrillo | Vice President Of Commercial Operations | Leadership |
Steven McElwaine | Chief Financial Officer | Leadership |
T. Liz Bailey | Director Of Business Development | Leadership |
Chris Holding | Director Of Operations | Leadership |
Marteen Besteder | Director Of Business Development | Leadership |
Kathleen Smith | Purchasing & Inventory Manager | Team |
Joel Dicandilo | Controller | Team |
Complete people profiles for Reaction Biology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reaction Biology
Reaction Biology has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bioassay, Peptide Specialty Laboratories and ProQinase.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Biological assays for pharmaceutical and chemical products are specialized in. | bioassay-online.de | Heidelberg, Germany | 2002 | Dec 2022 | •••• | |
Medical research lab services in peptide specialties are provided. | peptid.de | Heidelberg, Germany | 2000 | Dec 2022 | •••• | |
Contract research company for cancer drug discovery | proqinase.com | 2001 | Feb 2019 | •••• |
Complete acquisition details for Reaction Biology
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Reaction Biology
6 dated milestones of Reaction Biology across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Reaction Biology is founded.
- Funding First funding round of $751K.
- Acquisition Acquires ProQinase.
- Funding Latest funding round, Private Equity Round,.
- Acquisition Acquires Bioassay.
- Acquisition Acquires Peptide Specialty Laboratories.
Competitors of Reaction Biology
Reaction Biology has 3 listed competitors in our database, 2 of them funded. They include Chroma Medicine, FOXO Technologies and PhenoVista.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromamedicine.com | 2020 | Cambridge, United States | $135M | 122 | Epigenetic editing platform is developed for genomic medicines. | |
| foxotechnologies.com | 2020 | Minneapolis, United States | Epigenetic biomarkers are discovered and developed via AI platforms. | |||
| phenovista.com | 2014 | San Diego, United States | $3M | 11 | A CRO that provides phenotypic assay development and screening services. |
Detailed competitors of Reaction Biology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Reaction Biology
The website of Reaction Biology (reactionbiology.com) receives about 15.6K visits a month.
- Monthly visits15.6K
▲ 3.6% vs previous month
Websites whose visitors overlap most with Reaction Biology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medicilon.com | 100% | 4.4K | #3,585,560 | View details | |
| altogenlabs.com | 94% | 14K | #1,800,688 | View details | |
| bioz.com | 94% | 62.4K | #597,932 | View details | |
| promega.in | 91% | 16.8K | #1,538,231 | View details | |
promega.ca | promega.ca | 83% | #2,480,065 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Reaction Biology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Reaction Biology (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reaction Biology
Complete news archive for Reaction Biology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reaction Biology
Reaction Biology was founded in 2001 and raised its 1st funding round 4 years after it was founded.
Reaction Biology is headquartered in United States.
Reaction Biology has 77 employees.
Reaction Biology was founded in 2001 in the United States as a contract research organization focused on biotechnology. In vitro enzyme activity assays are offered for high-throughput screening and profiling, with specialization in kinase, epigenetic regulatory enzymes, and protease activities. Services include compound library screening, cell-based assays, CYP and hERG profiling, custom assay development, and protein microarray applications, supporting drug discovery efforts across various therapeutic areas.
Reaction Biology's top competitors include Chroma Medicine, FOXO Technologies and PhenoVista.
Reaction Biology has made 3 acquisitions, including Bioassay, Peptide Specialty Laboratories, and ProQinase.
Reaction Biology has 5 investors. Key investors include HHS, National Cancer Institute, Cobepa, National Center for Advancing Translational Sciences, and National Institute of Dental and Craniofacial Research.
Reaction Biology operates through Reaction Biology Europe Gmbh.